Literature DB >> 8998957

A generic toxicokinetic model for persistent lipophilic compounds in humans: an application to TCDD.

G W van der Molen1, S A Kooijman, W Slob.   

Abstract

This paper discusses a toxicokinetic model describing the distribution of TCDD in the human body during a lifetime. The model divides the body into several physiological compartments, their weights being functions of age. Ingested TCDD is instantaneously distributed over all compartments according to their lipid content. The liver eliminates TCDD from the body by a first-order process. Intake depends on age, as estimated from food consumption survey data combined with data on TCDD concentrations in various foods. It is shown that historical changes in intake, due to changes in environmental concentrations and in dietary habits, should be taken into account as well. Elimination rate and bioavailability, the only unknown parameters in the model, were estimated by calibrating the model to human data on internal concentrations. The generic formulation of the model makes it suitable for slowly eliminated lipophilic compounds in general.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8998957     DOI: 10.1006/faat.1996.0079

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  11 in total

1.  Application of pharmacokinetic modelling for 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure assessment.

Authors:  P Ruiz; L L Aylward; M Mumtaz
Journal:  SAR QSAR Environ Res       Date:  2014-11-14       Impact factor: 3.000

2.  A PBPK model describing a xenobiotic with a short PK event scale.

Authors:  Xiaofeng Wang; Brian E Davies
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-07-09       Impact factor: 2.745

3.  Determination of dioxins in human hair: Estimation of external and internal exposure to dioxins.

Authors:  Yuichi Miyabara; Noriko Nishimura; Chiharu Tohyama
Journal:  Environ Health Prev Med       Date:  2005-03       Impact factor: 3.674

Review 4.  Factors affecting the storage and excretion of toxic lipophilic xenobiotics.

Authors:  R J Jandacek; P Tso
Journal:  Lipids       Date:  2001-12       Impact factor: 1.880

5.  Understanding differences in the body burden-age relationships of bioaccumulating contaminants based on population cross sections versus individuals.

Authors:  Cristina L Quinn; Frank Wania
Journal:  Environ Health Perspect       Date:  2012-01-24       Impact factor: 9.031

6.  Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding.

Authors:  Meghan O'Grady Milbrath; Yvan Wenger; Chiung-Wen Chang; Claude Emond; David Garabrant; Brenda W Gillespie; Olivier Jolliet
Journal:  Environ Health Perspect       Date:  2008-10-03       Impact factor: 9.031

7.  A multi-individual pharmacokinetic model framework for interpreting time trends of persistent chemicals in human populations: application to a postban situation.

Authors:  Roland Ritter; Martin Scheringer; Matthew MacLeod; Urs Schenker; Konrad Hungerbühler
Journal:  Environ Health Perspect       Date:  2009-05-01       Impact factor: 9.031

8.  Quantitative relationship between the octanol/water partition coefficient and the diffusion limitation of the exchange between adipose and blood.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2010-01-07

9.  Host and environmental determinants of polychlorinated aromatic hydrocarbons in serum of adolescents.

Authors:  Tim S Nawrot; Jan A Staessen; Elly M Den Hond; Gudrun Koppen; Greet Schoeters; Robert Fagard; Lutgarde Thijs; Gerhard Winneke; Harry A Roels
Journal:  Environ Health Perspect       Date:  2002-06       Impact factor: 9.031

10.  Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studies.

Authors:  Marc-André Verner; Michel Charbonneau; Lizbeth López-Carrillo; Sami Haddad
Journal:  Environ Health Perspect       Date:  2008-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.